Ischemic heart disease is the leading cause of death in developed countries with mortality of about 18 % and no cure other than a heart transplant. CARE-MI is a project funded by the EU to use allogeneic cardiac stem cells (CSCs) or encapsulated growth factors to promote regeneration of damaged heart tissue.
Further information: cordis.europa.eu